论文部分内容阅读
瑞典乌普萨拉消息:据此地大学及生物医学中心研究人员报告,用人白细胞干扰素治疗晚期恶性胰腺癌初步结果令人鼓舞。对这些罕见肿瘤最初是用外科疗法,但确诊时,许多病人的肿瘤已转移。由于干扰素治疗类癌瘤有效,故瑞典小组在22名恶性胰腺癌患者中进行了干扰素试验。所有受试病人均属晚期。在试验开始时,18名病人对化疗无效,20名病人有肝转移,1名病人有肺转移,2名病人已扩散至骨骼。干扰素的给药方法是:前3天每日肌内或皮下注射3×10~6IU,
Uppsala, Sweden. According to reports from researchers at the University and Biomedical Center here, the preliminary results of the treatment of advanced malignant pancreatic cancer with human leukocyte interferon are encouraging. For these rare tumors, surgical therapy was initially used, but at the time of diagnosis many tumors have metastasized. Because interferon is effective in treating carcinoid tumors, the Swedish team conducted interferon tests in 22 patients with malignant pancreatic cancer. All the patients were advanced. At the start of the trial, 18 patients had no effect on chemotherapy, 20 had liver metastases, 1 had lung metastases, and 2 had spread to bone. The method of administration of interferon is: daily intramuscular or subcutaneous injection of 3 × 10 ~ 6IU in the first 3 days,